Abbott Laboratories
ABTNYSECIK 1800HealthcareFiscal year ends Dec 31
Reports and events: 321 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-2113:19 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-117587 |
| 2026-10-2111:36 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-066601 |
| 2026-08-2020:33 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-099247 |
| 2026-07-2820:02 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001628280-26-050134 |
| 2026-07-1611:36 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-048377 |
| 2026-04-2920:05 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001628280-26-028357 |
| 2026-04-2720:06 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001104659-26-049434 |
| 2026-04-1720:04 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-044892 |
| 2026-04-1611:36 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-025365 |
| 2026-03-2312:54 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-033079 |
| 2026-03-1320:00 ET | DEF 14A | Proxy statementPeriod 2026-04-24 | 0001308179-26-000064 |
| 2026-03-0920:21 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001104659-26-025240 |
| 2026-02-2621:16 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001104659-26-020509 |
| 2026-02-2021:17 ET | 8-K | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001104659-26-018167 |
| 2026-02-2021:05 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001628280-26-010185 |
| 2026-01-2212:35 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-002982 |
| 2025-12-1221:10 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001104659-25-120657 |
| 2025-11-2121:06 ET | 8-K | 5.04 Item not in the standard list; 9.01 Financial statements and exhibits | 0001104659-25-114995 |
| 2025-11-2012:37 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-114422 |
| 2025-10-2920:22 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001628280-25-047131 |
| 2025-10-1511:33 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-25-045049 |
| 2025-07-3020:14 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001628280-25-036720 |
| 2025-07-1711:34 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-25-035135 |
| 2025-05-0120:01 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001104659-25-043508 |
| 2025-04-3020:14 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001628280-25-021090 |
| 2025-04-2820:10 ET | 8-K | 5.07 Shareholder vote results | 0001104659-25-040201 |
| 2025-04-1611:36 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-25-017924 |
| 2025-03-1420:07 ET | DEF 14A | Proxy statementPeriod 2025-04-25 | 0001308179-25-000134 |
| 2025-02-2121:07 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001628280-25-007110 |
| 2025-01-2212:13 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-25-002092 |
| 2024-11-1521:13 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001104659-24-119717 |
| 2024-10-3121:14 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001628280-24-044602 |
| 2024-10-1611:37 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-24-042893 |
| 2024-07-3120:02 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001628280-24-033740 |
| 2024-07-1811:37 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-24-032182 |
| 2024-05-0220:11 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0001628280-24-020011 |
| 2024-05-0120:02 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001104659-24-055724 |
| 2024-04-2920:08 ET | 8-K | 5.07 Shareholder vote results | 0001104659-24-054016 |
| 2024-04-1711:36 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-24-016497 |
| 2024-03-1520:03 ET | DEF 14A | Proxy statementPeriod 2024-04-26 | 0001308179-24-000182 |
| 2024-02-1621:15 ET | 10-K | Annual reportPeriod 2023-12-31 | 0001628280-24-005348 |
| 2024-01-2921:10 ET | 8-K | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.03 New direct financial obligation | 0001104659-24-007725 |
| 2024-01-2412:36 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-24-002009 |
| 2023-11-0120:07 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0001628280-23-035957 |
| 2023-10-1811:37 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-23-034544 |
| 2023-09-0120:13 ET | 8-K/A | 5.07 Shareholder vote results | 0001104659-23-097759 |
| 2023-08-0320:07 ET | 10-Q | Quarterly reportPeriod 2023-06-30 | 0001628280-23-027203 |
| 2023-07-2012:29 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-23-025156 |
| 2023-06-1214:32 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001104659-23-070203 |
| 2023-06-0920:05 ET | 8-K/A | 5.07 Shareholder vote results | 0001104659-23-069894 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 14:50 ET. Listed shows no prices and gives no investment advice.